Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Metastasis”

3,276 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,276 results

Testing effectiveness (Phase 2)Study completedNCT00684099
What this trial is testing

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 70
Not applicableLooking for participantsNCT05889247
What this trial is testing

Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Zealand University Hospital 350
Not applicableStudy completedNCT02801409
What this trial is testing

Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery

Who this might be right for
Lung CancerThoracic SurgeryAnesthesia, Epidural+2 more
Peking University First Hospital 400
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Early research (Phase 1)Ended earlyNCT02309892
What this trial is testing

A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Helix BioPharma Corporation 14
Not applicableUnknownNCT04547634
What this trial is testing

Telerehabilitation in Oncology Patients

Who this might be right for
Cancer MetastaticCancerSurvivorship
University of Malaga 30
Early research (Phase 1)Study completedNCT04330664
What this trial is testing

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 86
Not applicableStudy completedNCT04879316
What this trial is testing

Energy for Lymphocytes

Who this might be right for
Non-small Cell Lung CancerProgression, Disease
Hôpital Cochin 144
Testing effectiveness (Phase 2)Ended earlyNCT04610684
What this trial is testing

Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases

Who this might be right for
Small-cell Lung CancerBrain Metastases
Jeffrey Clarke 3
Early research (Phase 1)Looking for participantsNCT06479811
What this trial is testing

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Who this might be right for
Head and Neck TumorsKidney CancersSmall Cell Lung Cancers+3 more
National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)Study completedNCT00867009
What this trial is testing

Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Eli Lilly and Company 113
Testing effectiveness (Phase 2)Ended earlyNCT03382899
What this trial is testing

Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 101
Testing effectiveness (Phase 2)Study completedNCT00003231
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Swiss Cancer Institute 40
Not applicableEnded earlyNCT02671045
What this trial is testing

Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-small Cell Lung
Cota Inc. 649
Testing effectiveness (Phase 2)Active Not RecruitingNCT04902872
What this trial is testing

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
Solid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more
Cybrexa Therapeutics 130
Not applicableLooking for participantsNCT06448793
What this trial is testing

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 55
Testing effectiveness (Phase 2)Study completedNCT02031458
What this trial is testing

Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 667
Not applicableStudy completedNCT02392455
What this trial is testing

VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 817
Testing effectiveness (Phase 2)Study completedNCT03812809
What this trial is testing

A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive

Who this might be right for
NSCLC
Beta Pharma Shanghai 226
Large-scale testing (Phase 3)UnknownNCT00268684
What this trial is testing

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Tel-Aviv Sourasky Medical Center 381
Load More Results